GLPG Stock Summary and Trading Ideas (Galapagos Nv - American Depositary Shares | NASDAQ:GLPG)

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Galapagos Nv - American Depositary Shares trades on the NASDAQ stock market under the symbol GLPG.

As of April 18, 2024, GLPG stock price declined to $28.91 with 121,893 million shares trading.

GLPG has a beta of 0.90, meaning it tends to be less sensitive to market movements. GLPG has a correlation of 0.11 to the broad based SPY ETF.

GLPG has a market cap of $1.90 billion. This is considered a Small Cap stock.

In the last 3 years, GLPG stock traded as high as $83.77 and as low as $28.82.

The top ETF exchange traded funds that GLPG belongs to (by Net Assets): IBB, SBIO, APIE, AVDE, BIB.

GLPG has underperformed the market in the last year with a price return of -22.8% while the SPY ETF gained +22.2%. GLPG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.6% and -9.1%, respectively, while the SPY returned +5.2% and -2.6%, respectively.

GLPG support price is $28.86 and resistance is $29.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GLPG stock will trade within this expected range on the day.